LERNER RICHARD A 4

4 · Intra-Cellular Therapies, Inc. · Filed May 13, 2020

Form 4

Period: 2020-05-11

Director

Transactions

Exercise/Conversion
Common Stock
2020-05-11$2.74/sh+25,000$68,500→ 97,313 total(indirect: By Trust)
Sale
Common Stock
2020-05-11$20.50/sh−3,500$71,750→ 93,813 total(indirect: By Trust)
Exercise/Conversion
Stock Option (right to buy)
2020-05-11−12,500→ 0 total
Exercise: $2.74Exp: 2020-06-10→ Common Stock (12,500 underlying)
Exercise/Conversion
Stock Option (right to buy)
2020-05-11−12,500→ 0 total
Exercise: $2.74Exp: 2020-12-21→ Common Stock (12,500 underlying)

Holdings

Footnotes (4)

[F1]Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein.
[F2]The proceeds from this sale will be used primarily to cover the reporting person's tax liability arising from the exercise of options.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.50 to $20.51 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
[F4]All shares underlying this option have vested.

Documents

1 file